People

Abe Bassan
Biotechnology investor at Samsara BioCapital with earlier drug-development experience at Revolution Medicines and bluebird bio. Abe Bassan is listed by Samsara BioCapital as Partner. Abraham Bassan joined at the 2017 fund launch after program-biology leadership at Revolution Medicines and drug-development work at bluebird bio.
Roles
Nura Bio
CurrentBoard Director
Samsara BioCapital
CurrentPartner